Back to Jane Street Group, LLC Jane Street Group, LLC

COGT

Showing 8 of 18 quarters

Position history for Jane Street Group, LLCJane Street Group, LLC's holdings in Cogent Biosciences, Inc.

No. Jane Street Group exited its COGT (Cogent Biosciences) position in Q2 2026. Its Q1 2026 13F listed 5,483 shares worth $211,041. Jane Street Group first reported COGT in Q2 2021 and held it in 13 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$1.2M

Total Shares Change

-111,863

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$38.70
0
2026-Q1
New
5,483
-
$211,0410.0%$38.49
35
2025-Q4
Exited
0
-100.0%
$00.0%$35.52
0
2025-Q3
New
148,401
-
$2.1M0.0%$14.36
36
2025-Q2
Exited
0
-100.0%
$00.0%$7.18
0
2025-Q1
Increased
123,822
+66.2%
$741,6940.0%$5.99
36
2024-Q4
Decreased
74,484
-33.4%
$580,9750.0%$7.80
0
2024-Q3
Decreased
111,863
-55.0%
$1.2M0.0%$10.80
0

Other major holders of COGT: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used